Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Conditions

Lupus Erythematosus, Systemic 1Infectious Mononucleosis 1Infections 1Fatigue Syndrome, Chronic 1Epstein-Barr Virus Infections 1

Interventions

Trimethoprim, Sulfamethoxazole Drug Combination 9Ciprofloxacin 7gamma-Globulins 3Voriconazole 3Fluconazole 3Daptomycin 3Antibiotic Prophylaxis 3Amoxicillin-Potassium Clavulanate Combination 3Whole-Body Irradiation 2Vancomycin 2Trimethoprim 2Sulfamethoxazole 2Saline Solution 2Ribavirin 2Peripheral Blood Stem Cell Transplantation 2Pentetic Acid 2Melphalan 2Itraconazole 2Immunoglobulins, Intravenous 2Fosfomycin 2Ethanol 2Cyclophosphamide 2Cefazolin 2Caspofungin 2ziprasidone 1tocilizumab 1telavancin 1telaprevir 1talquetamab 1soybean oil, phospholipid emulsion 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Infections × Procalcitonin × Clear all
NCT05127980 2025-02-25

Occurrence of Antibodies Cross-reacting With Autoantigens in Primary EBV Infection

University Hospital, Basel, Switzerland

Recruiting
80 enrolled

Infections, Infectious Mononucleosis, Lupus Erythematosus, Systemic, Fatigue Syndrome, Chronic, Epstein-Barr Virus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡